Please use this identifier to cite or link to this item:
http://hdl.handle.net/2445/195454
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Segura, Alex G. | - |
dc.contributor.author | Martínez Pinteño, Albert | - |
dc.contributor.author | Gassó Astorga, Patricia | - |
dc.contributor.author | Rodríguez Ferret, Natalia | - |
dc.contributor.author | Bioque Alcázar, Miquel | - |
dc.contributor.author | Cuesta, Manuel J. | - |
dc.contributor.author | González Peñas, Javier | - |
dc.contributor.author | García Rizo, Clemente | - |
dc.contributor.author | Lobo, Antonio | - |
dc.contributor.author | González-Pinto, Ana | - |
dc.contributor.author | García Alcón, Alicia | - |
dc.contributor.author | Roldán, Alexandra | - |
dc.contributor.author | Vieta i Pascual, Eduard, 1963- | - |
dc.contributor.author | Castro Fornieles, Josefina | - |
dc.contributor.author | Mané Santacana, Anna | - |
dc.contributor.author | Saiz Ruiz, Jerónimo | - |
dc.contributor.author | Bernardo Arroyo, Miquel | - |
dc.contributor.author | Mas Herrero, Sergi | - |
dc.contributor.author | Mezquida Mateos, Gisela | - |
dc.contributor.author | PEPs Group | - |
dc.date.accessioned | 2023-03-17T15:04:59Z | - |
dc.date.available | 2023-03-17T15:04:59Z | - |
dc.date.issued | 2022-05-31 | - |
dc.identifier.issn | 0920-9964 | - |
dc.identifier.uri | http://hdl.handle.net/2445/195454 | - |
dc.description.abstract | Objective: Metabolic syndrome is a health-threatening condition suffered by approximately one third of schizophrenia patients and largely attributed to antipsychotic medication. Previous evidence reports a common genetic background of psychotic and metabolic disorders. In this study, we aimed to assess the role of polygenic risk scores (PRSs) on the progression of the metabolic profile in a first-episode psychosis (FEP) cohort. Method: Of the 231 FEP individuals included in the study, 192-220 participants were included in basal analysis and 118-179 in longitudinal 6-month models. Eleven psychopathologic and metabolic PRSs were constructed. Basal and longitudinal PRSs association with metabolic measurements was assessed by statistical analyses. Results: No major association of psychopathological PRSs with the metabolic progression was found. However, high risk individuals for depression and cholesterol-related PRSs reported a higher increase of cholesterol levels during the follow-up (FDR ≤ 0.023 for all analyses). Their effect was comparable to other well-established pharmacological and environmental risk factors (explaining at least 1.2% of total variance). Conclusion: Our findings provide new evidence of the effects of metabolic genetic risk on the development of metabolic dysregulation. The future establishment of genetic profiling tools in clinical procedures could enable practitioners to better personalize antipsychotic treatment selection and dosage. | - |
dc.format.extent | 10 p. | - |
dc.format.mimetype | application/pdf | - |
dc.language.iso | eng | - |
dc.publisher | Elsevier B.V. | - |
dc.relation.isformatof | Reproducció del document publicat a: https://doi.org/10.1016/j.schres.2022.05.021 | - |
dc.relation.ispartof | Schizophrenia Research, 2022, vol. 244, p. 101-110 | - |
dc.relation.uri | https://doi.org/10.1016/j.schres.2022.05.021 | - |
dc.rights | cc-by-nc-nd (c) Elsevier B.V., 2022 | - |
dc.rights.uri | https://creativecommons.org/licenses/by-nc-nd/4.0/ | - |
dc.source | Articles publicats en revistes (Fonaments Clínics) | - |
dc.subject.classification | Trastorns del metabolisme | - |
dc.subject.classification | Síndrome metabòlica | - |
dc.subject.classification | Factors de risc en les malalties | - |
dc.subject.classification | Psicosi | - |
dc.subject.classification | Antipsicòtics | - |
dc.subject.other | Disorders of metabolism | - |
dc.subject.other | Metabolic syndrome | - |
dc.subject.other | Risk factors in diseases | - |
dc.subject.other | Psychoses | - |
dc.subject.other | Antipsychotic drugs | - |
dc.title | Metabolic polygenic risk scores effect on antipsychotic-induced metabolic dysregulation: A longitudinal study in a first episode psychosis cohort | - |
dc.type | info:eu-repo/semantics/article | - |
dc.type | info:eu-repo/semantics/publishedVersion | - |
dc.identifier.idgrec | 723859 | - |
dc.date.updated | 2023-03-17T15:05:00Z | - |
dc.rights.accessRights | info:eu-repo/semantics/openAccess | - |
dc.identifier.pmid | 35659654 | - |
Appears in Collections: | Articles publicats en revistes (Institut de Neurociències (UBNeuro)) Articles publicats en revistes (IDIBAPS: Institut d'investigacions Biomèdiques August Pi i Sunyer) Articles publicats en revistes (Fonaments Clínics) |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
723859.pdf | 1.09 MB | Adobe PDF | View/Open |
This item is licensed under a
Creative Commons License